(Q36695898)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15354209%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

title

Phase II trial of the antiangiogenic agent IM862 in metastatic renal cell carcinoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15354209%20AND%20SRC:MED&resulttype=core&format=json

metastatic renal cell carcinoma

1 January 2020

main subject

phase II clinical trial

0 references

angiogenesis inhibitor

1 reference

1 reference

1 reference

inferred from title

author

Srinivasan Madhusudan

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15354209%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Philip H. Jones

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15354209%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Adrian Harris

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15354209%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

author name string

Deplanque G

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15354209%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Wellmann S

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15354209%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Christodoulos K

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15354209%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Talbot DC

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15354209%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Ganesan TS

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15354209%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Blann A

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15354209%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

language of work or name

English

0 references

publication date

1 November 2004

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15354209%20AND%20SRC:MED&resulttype=core&format=json

British Journal of Cancer

1 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15354209%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

volume

91

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15354209%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15354209%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

page(s)

1645-1650

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15354209%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/sj.bjc.6602126

1 January 2020

exact match

0 references

cites work

Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409952

A randomized trial of bevacizumab, an anti-vascular endothelial growth factor antibody, for metastatic renal cancer

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409952

Circulating angiogenesis regulators in cancer patients.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409952

Anti-angiogenic agents: clinical trial design and therapies in development

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409952

Continuous low-dose therapy with vinblastine and VEGF receptor-2 antibody induces sustained tumor regression without overt toxicity

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409952

Novel investigative approaches for advanced renal cell carcinoma

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409952

Interferon in metastatic renal cell carcinoma.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409952

Antiangiogenic treatment enhances photodynamic therapy responsiveness in a mouse mammary carcinoma

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409952

Results of a randomized study of IM862 nasal solution in the treatment of AIDS-related Kaposi's sarcoma

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409952

Are angiostatin and endostatin cures for cancer?

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409952

Natural history and therapy of metastatic renal cell carcinoma: the role of interleukin-2.

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409952

Multi-institutional study of the angiogenesis inhibitor TNP-470 in metastatic renal carcinoma

28 June 2018

1 reference

12 December 2020

1 reference

12 December 2020

A Phase II trial of bryostatin-1 for patients with metastatic renal cell carcinoma

1 reference

12 December 2020

A phase II study of razoxane, an antiangiogenic topoisomerase II inhibitor, in renal cell cancer with assessment of potential surrogate markers of angiogenesis

1 reference

12 December 2020

Prognostic value of plasma vascular endothelial growth factor in patients with colorectal cancer

1 reference

12 December 2020

Elevated perioperative serum vascular endothelial growth factor levels in patients with colon carcinoma

1 reference

12 December 2020

ELISA determination of soluble urokinase receptor in blood from healthy donors and cancer patients

1 reference

12 December 2020

Interferon-alpha and survival in metastatic renal carcinoma: early results of a randomised controlled trial. Medical Research Council Renal Cancer Collaborators

1 reference

12 December 2020

Regimens with or without interferon-alpha as treatment for metastatic melanoma and renal cell carcinoma: an overview of randomized trials

1 reference

12 December 2020

Identifiers

DOI

10.1038/SJ.BJC.6602126

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15354209%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15354209%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

PubMed publication ID

15354209

1 reference